Dr. Jeyhan Dhabhar

Dr. Jeyhan Dhabhar is a Consultant Medical Oncologist and Hemato-Oncologist based at Gleneagles Hospital, Mumbai, with over 7 years of clinical experience in comprehensive cancer care. He holds an MBBS degree, MD in Internal Medicine, and DNB in Oncology, complemented by international perceptorships and certifications that strengthen his clinical expertise. His specialization in precision oncology reflects a commitment to delivering personalized cancer treatment tailored to each patient's molecular and clinical profile.

Dr. Dhabhar's clinical depth spans advanced cancer treatment modalities including chemotherapy, targeted therapy, cancer immunotherapy, and hormone therapies for breast, prostate, and gynecologic malignancies. He is recognized for his expertise in cancer genomics and his ability to integrate cutting-edge therapeutic approaches with robust clinical judgment. His approach prioritizes maximum therapeutic benefit with minimal treatment-related toxicity, ensuring patients receive evidence-based care optimized for their specific condition.

Throughout his career, Dr. Dhabhar has treated a diverse patient base, including international patients from the Gulf, Africa, and South Asia seeking specialized oncology care. He is fluent in English and Hindi, facilitating seamless communication with patients across regions. His practice at Gleneagles Hospital positions him to serve medical tourists and expatriate patients requiring complex oncology management.

Gleneagles Hospital, Mumbai, is a NABH-accredited tertiary care center equipped with advanced oncology infrastructure, including state-of-the-art chemotherapy units, diagnostic imaging, and multidisciplinary tumor boards. The hospital's international patient services and modern facilities make it a preferred destination for cancer patients seeking world-standard care at accessible costs. Dr. Dhabhar's editorial presence on the Editorial Board of the Science Publishing Group, New York, and his role as Honorary Reviewer for the Ochsner Journal underscore his commitment to advancing oncology research and evidence-based practice. International patients benefit from his comprehensive approach and the hospital's seamless coordination of care.